0001225208-15-016754.txt : 20150812
0001225208-15-016754.hdr.sgml : 20150812
20150812163018
ACCESSION NUMBER: 0001225208-15-016754
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150810
FILED AS OF DATE: 20150812
DATE AS OF CHANGE: 20150812
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
BUSINESS PHONE: 604-629-9223
MAIL ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 151047326
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER NAME:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2015-08-10
1
0001404644
AQUINOX PHARMACEUTICALS, INC
AQXP
0000078003
PFIZER INC
235 EAST 42ND ST
NEW YORK
NY
10017
1
Common Stock
2015-08-10
4
S
0
18.0000
29.0000
D
1235312.0000
D
Common Stock
2015-08-10
4
S
0
2840.0000
41.2475
D
1232472.0000
D
Common Stock
2015-08-10
4
S
0
2975.0000
28.4670
D
1229497.0000
D
Common Stock
2015-08-10
4
S
0
3207.0000
35.6072
D
1226290.0000
D
Common Stock
2015-08-10
4
S
0
6073.0000
40.2955
D
1220217.0000
D
Common Stock
2015-08-10
4
S
0
8565.0000
27.3561
D
1211652.0000
D
Common Stock
2015-08-10
4
S
0
8969.0000
21.4506
D
1202683.0000
D
Common Stock
2015-08-10
4
S
0
9142.0000
39.5172
D
1193541.0000
D
Common Stock
2015-08-10
4
S
0
9901.0000
37.2264
D
1183640.0000
D
Common Stock
2015-08-10
4
S
0
10544.0000
36.3687
D
1173096.0000
D
Common Stock
2015-08-10
4
S
0
11627.0000
38.4947
D
1161469.0000
D
Common Stock
2015-08-10
4
S
0
12726.0000
25.3233
D
1148743.0000
D
Common Stock
2015-08-10
4
S
0
13109.0000
26.3213
D
1135634.0000
D
Common Stock
2015-08-10
4
S
0
25931.0000
20.3476
D
1109703.0000
D
Common Stock
2015-08-10
4
S
0
31400.0000
24.3129
D
1078303.0000
D
Common Stock
2015-08-10
4
S
0
44268.0000
22.5994
D
1034035.0000
D
Common Stock
2015-08-10
4
S
0
58632.0000
23.4112
D
975403.0000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.46, inclusive. The reporting person undertakes to provide to Aquinox Pharmaceuticals Inc., the "Issuer", any security holder of the Issuer, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1) through (16) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.90, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.25 to $35.94, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.90, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.01 to $21.87, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.90, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.93, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.82, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.90, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.98, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive.
/s/ Susan Grant, Asst. Secretary of Pfizer Inc.
2015-08-12